Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer Journal Article


Authors: Paffenholz, S. V.; Salvagno, C.; Ho, Y. J.; Limjoco, M.; Baslan, T.; Tian, S.; Kulick, A.; de Stanchina, E.; Wilkinson, J. E.; Barriga, F. M.; Zamarin, D.; Cubillos-Ruiz, J. R.; Leibold, J.; Lowe, S. W.
Article Title: Senescence induction dictates response to chemo- and immunotherapy in preclinical models of ovarian cancer
Abstract: High-grade serous ovarian carcinoma (HGSOC) is a cancer with dismal prognosis due to the limited effectiveness of existing chemo- and immunotherapies. To elucidate mechanisms mediating sensitivity or resistance to these therapies, we developed a fast and flexible autochthonous mouse model based on somatic introduction of HGSOC-associated genetic alterations into the ovary of immunocompetent mice using tissue electroporation. Tumors arising in these mice recapitulate the metastatic patterns and histological, molecular, and treatment response features of the human disease. By leveraging these models, we show that the ability to undergo senescence underlies the clinically observed increase in sensitivity of homologous recombination (HR)–deficient HGSOC tumors to platinum-based chemotherapy. Further, cGas/STING-mediated activation of a restricted senescence-associated secretory phenotype (SASP) was sufficient to induce immune infiltration and sensitize HR-deficient tumors to immune checkpoint blockade. In sum, our study identifies senescence propensity as a predictor of therapy response and defines a limited SASP profile that appears sufficient to confer added vulnerability to concurrent immunotherapy and, more broadly, provides a blueprint for the implementation of electroporation-based mouse models to reveal mechanisms of oncogenesis and therapy response in HGSOC. © 2022 National Academy of Sciences. All rights reserved.
Keywords: ovarian cancer; cancer immunotherapy; senescence; mouse models
Journal Title: Proceedings of the National Academy of Sciences of the United States of America
Volume: 119
Issue: 5
ISSN: 0027-8424
Publisher: National Academy of Sciences  
Date Published: 2022-02-01
Start Page: e2117754119
Language: English
DOI: 10.1073/pnas.2117754119
PUBMED: 35082152
PROVIDER: scopus
PMCID: PMC8812522
DOI/URL:
Notes: Article -- Export Date: 1 March 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Dmitriy Zamarin
    201 Zamarin
  2. Scott W Lowe
    249 Lowe
  3. Sha Tian
    14 Tian
  4. Timour Baslan
    46 Baslan
  5. Amanda Kulick
    24 Kulick
  6. Josef Leibold
    16 Leibold
  7. Yu-jui Ho
    40 Ho
  8. Francisco M Barriga
    12 Barriga